These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11878919)

  • 1. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus.
    Germi R; Crance JM; Garin D; Guimet J; Lortat-Jacob H; Ruigrok RW; Zarski JP; Drouet E
    Virology; 2002 Jan; 292(1):162-8. PubMed ID: 11878919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The standardization of the plaque reduction technic for differentiating a dengue infection from a yellow fever infection].
    Alvarez Vera M; Valdés Palacios D; Vázquez Ramudo S; Delgado Hernández I; García Infante S; Morier Díaz L; Guzmán Tirado MG
    Rev Cubana Med Trop; 1998; 50(3):177-81. PubMed ID: 10349439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.
    Mantel N; Aguirre M; Gulia S; Girerd-Chambaz Y; Colombani S; Moste C; Barban V
    J Virol Methods; 2008 Jul; 151(1):40-6. PubMed ID: 18501437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.
    Chen Y; Maguire T; Hileman RE; Fromm JR; Esko JD; Linhardt RJ; Marks RM
    Nat Med; 1997 Aug; 3(8):866-71. PubMed ID: 9256277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates.
    McGee CE; Lewis MG; Claire MS; Wagner W; Lang J; Guy B; Tsetsarkin K; Higgs S; Decelle T
    J Infect Dis; 2008 Mar; 197(5):693-7. PubMed ID: 18266603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reflection on 2 current viral diseases: yellow fever and dengue].
    Chastel C
    Ann Biol Clin (Paris); 1997; 55(5):415-24. PubMed ID: 9347008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of yellow fever.
    Monath TP
    Antiviral Res; 2008 Apr; 78(1):116-24. PubMed ID: 18061688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild terrestrial rainforest mammals as potential reservoirs for flaviviruses (yellow fever, dengue 2 and St Louis encephalitis viruses) in French Guiana.
    de Thoisy B; Dussart P; Kazanji M
    Trans R Soc Trop Med Hyg; 2004 Jul; 98(7):409-12. PubMed ID: 15138077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?
    Gubler DJ
    Comp Immunol Microbiol Infect Dis; 2004 Sep; 27(5):319-30. PubMed ID: 15225982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes.
    Hilgard P; Stockert R
    Hepatology; 2000 Nov; 32(5):1069-77. PubMed ID: 11050058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
    Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
    Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection.
    Martínez-Barragán JJ; del Angel RM
    J Virol; 2001 Sep; 75(17):7818-27. PubMed ID: 11483725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA; Lozach PY; Amara A; Gamarnik AV
    J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the steps involved in Dengue virus entry into host cells.
    Hung SL; Lee PL; Chen HW; Chen LK; Kao CL; King CC
    Virology; 1999 Apr; 257(1):156-67. PubMed ID: 10208929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells.
    Misinzo G; Delputte PL; Meerts P; Lefebvre DJ; Nauwynck HJ
    J Virol; 2006 Apr; 80(7):3487-94. PubMed ID: 16537616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.